临床药师对1例骨肉瘤患者进行围化疗期药学监护  

Peri-chemotherapy pharmaceutical monitoring of clinical pharmacist on an osteosarcoma patient

作　　者：赵德华[1] 龙小庆[2] 江东 陈静[1] 王继生[1] ZHAO Dehua;LONG Xiaoqing;JIANG Dong;CHEN Jing;WANG Jisheng(Department of Clinical Pharmacy,the Third Hospital of Mianyang/Sichuan Mental Health Center,Mianyang,621000,Sichuan,China;Department of Oncology,the Third Hospital of Mianyang/Sichuan Mental Health Center,Mianyang,621000,Sichuan,China)

机构地区：[1]绵阳市第三人民医院/四川省精神卫生中心临床药学科,四川绵阳621000 [2]绵阳市第三人民医院/四川省精神卫生中心肿瘤科,四川绵阳621000

出　　处：《肿瘤药学》2024年第2期242-247,共6页Anti-Tumor Pharmacy

摘　　要：目的探讨抗肿瘤药物专业临床药师参与肿瘤患者治疗的药学实践。方法通过对1例骨肉瘤患者进行围化疗期药学监护,阐述临床药师在肿瘤患者治疗中的作用。结果临床药师参与了肿瘤患者的全程治疗,医师和护理人员采纳临床药师的建议,患者顺利完成了第1周期化疗。结论围化疗期药学监护注重监护的时间和内容,可对患者进行有针对性和计划性的药学监护,是临床药师参与肿瘤患者治疗的重要切入点,有助于临床药师将自身专业知识转变成专业能力,从而更好地开展药学服务工作。Objective To explore the pharmaceutical practice of clinical pharmacists in the treatment of cancer patients.Methods The role of clinical pharmacists in the treatment of cancer patients was illustrated by taking peri-chemotherapy pharmaceutical monitoring on an osteosarcoma patient.Results Clinical pharmacists participated in the whole treatment of the cancer patient.Clinicians and nurses adopted the recommendations of clinical pharmacists,and the patient successfully completed the first chemotherapy cycle.Conclusion Peri-chemotherapy pharmaceutical monitoring laid emphasis on the monitoring time and content,providing targeted and planned pharmaceutical care for cancer patients.Therefore,it is an important entry point for clinical pharmacists to participate in the treatment of cancer patients.It is also helpful for clinical pharmacists to transform their professional knowledge into professional ability,so as to provide a better pharmaceutical care.

关 键 词：临床药师 骨肉瘤 围化疗期 药学监护 药学服务 

分 类 号：R738.1[医药卫生—肿瘤]